{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:29:34Z","timestamp":1789626574028,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>A central strategy of tuberculosis (TB) control in the United States is reducing the burden of latent TB infection (LTBI) through targeted testing and treatment of persons with untreated LTBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The objective of the study was to provide estimates of and risk factors for engagement in LTBI care in the overall U.S. population and among specific risk groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used nationally representative data from 7,080 participants in the 2011\u20132012 National Health and Nutrition Examination Survey. Engagement in LTBI care was assessed by estimating the proportion with a history of testing, diagnosis, treatment initiation, and treatment completion. Weighted methods were used to account for the complex survey design and to derive national estimates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Only 1.4 million (10%) of an estimated 14.0 million individuals with an LTBI had previously completed treatment. Of the 12.6 million who did not complete LTBI treatment, 3.7 million (29%) had never been tested and 7.2 million (57%) received testing but had no history of diagnosis. High-risk groups showed low levels of engagement, including contacts of individuals with TB and persons born outside the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There is a reservoir of more than 12 million individuals in the United States who may be at risk for progression to TB disease and potential transmission. TB control programs and community providers should consider focused efforts to increase testing, diagnosis, and treatment for LTBI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202009-1153oc","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T19:07:38Z","timestamp":1615230458000},"page":"1669-1676","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":12,"title":["Self-reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection: 2011\u20132012"],"prefix":"10.1093","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0717-8202","authenticated-orcid":false,"given":"James D.","family":"Mancuso","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roque","family":"Miramontes","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla A.","family":"Winston","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"C. Robert","family":"Horsburgh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology"},{"name":"Department of Biostatistics, and"},{"name":"Department of Global Health, School of Public Health, and"},{"name":"Department of Medicine, School of Medicine, Boston University Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Hill","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"2026012203503168900_bib1","doi-asserted-by":"crossref","first-page":"e0140881","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis infection in the United States: prevalence estimates from the national health and nutrition examination survey, 2011-2012","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"key":"2026012203503168900_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1164\/rccm.201508-1683OC","article-title":"The prevalence of latent tuberculosis infection in the United States","volume":"194","author":"Mancuso","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203503168900_bib3","first-page":"1","article-title":"Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America","volume-title":"MMWR Recomm Rep","author":"Taylor","year":"2005"},{"key":"2026012203503168900_bib4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: US preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"2026012203503168900_bib5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2026012203503168900_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5588\/ijtld.12.0697","article-title":"Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada","volume":"17","author":"Colson","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026012203503168900_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","article-title":"Latent TB infection treatment acceptance and completion in the United States and Canada","volume":"137","author":"Horsburgh","year":"2010","journal-title":"Chest"},{"key":"2026012203503168900_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2458-12-468","article-title":"Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study","volume":"12","author":"Goswami","year":"2012","journal-title":"BMC Public Health"},{"key":"2026012203503168900_bib9","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1016\/j.ijid.2009.05.007","article-title":"Adherence to treatment of latent tuberculosis infection in a clinical population in New York City","volume":"14","author":"Li","year":"2010","journal-title":"Int J Infect Dis"},{"key":"2026012203503168900_bib10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jinf.2006.04.010","article-title":"Predictors of failure to complete treatment for latent tuberculosis infection","volume":"54","author":"Parsyan","year":"2007","journal-title":"J Infect"},{"key":"2026012203503168900_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.200510-1667OC","article-title":"Predicting non-completion of treatment for latent tuberculous infection: a prospective survey","volume":"174","author":"Shieh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203503168900_bib12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1378\/chest.07-2024","article-title":"Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island","volume":"133","author":"Kwara","year":"2008","journal-title":"Chest"},{"key":"2026012203503168900_bib13","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.15585\/mmwr.mm6450a1","article-title":"Tuberculosis contact investigations: United States, 2003-2012","volume":"64","author":"Young","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026012203503168900_bib14","first-page":"1235","article-title":"Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada","volume":"12","author":"Hirsch-Moverman","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026012203503168900_bib15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12879-019-4557-3","article-title":"The latent tuberculosis infection cascade of care in Iqaluit, Nunavut, 2012-2016","volume":"19","author":"Pease","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2026012203503168900_bib16","author":"National Center for Health Statistics"},{"key":"2026012203503168900_bib17","volume-title":"R: A language and environment for statistical computing","author":"R Core Team"},{"key":"2026012203503168900_bib18","volume-title":"Package \u2018survey\u2019: analysis of complex survey samples","author":"Lumley","year":"2017"},{"key":"2026012203503168900_bib19","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3201\/eid2510.190439","article-title":"Factoring prior treatment into tuberculosis infection prevalence estimates, United States, 2011-2012","volume":"25","author":"Vonnahme","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2026012203503168900_bib20","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection: American Thoracic Society","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"2026012203503168900_bib21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026012203503168900_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1164\/rccm.200404-478OC","article-title":"Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months","volume":"170","author":"Menzies","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203503168900_bib23","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012203503168900_bib24","volume-title":"Healthy people 2020: immunization and infectious diseases","author":"U.S. Department of Health and Human Services","year":"2015"},{"key":"2026012203503168900_bib25","volume-title":"National TB program objectives and performance targets for 2025: Centers for Disease Control and Prevention","author":"Centers for Disease Control and Prevention (Division of Tuberculosis Elimination)","year":"2019"},{"key":"2026012203503168900_bib26","doi-asserted-by":"crossref","first-page":"e0180707","DOI":"10.1371\/journal.pone.0180707","article-title":"Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: a systematic review","volume":"12","author":"Malekinejad","year":"2017","journal-title":"PLoS One"},{"key":"2026012203503168900_bib27","volume-title":"Reported tuberculosis in the United States, 2018","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"2026012203503168900_bib28","first-page":"2","article-title":"Development and implementation of a cohort review for latent tuberculosis infection","volume":"21","author":"Aaron","year":"2014","journal-title":"MSMR"},{"key":"2026012203503168900_bib29","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"key":"2026012203503168900_bib30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s12889-018-5393-x","article-title":"Care cascade for targeted tuberculosis testing and linkage to care in homeless populations in the United States: a meta-analysis","volume":"18","author":"Parriott","year":"2018","journal-title":"BMC Public Health"},{"key":"2026012203503168900_bib31","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/aje\/kwy094","article-title":"Prospects for tuberculosis elimination in the United States: results of a transmission dynamic model","volume":"187","author":"Menzies","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2026012203503168900_bib32","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1473-3099(17)30248-7","article-title":"Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA","volume":"17","author":"LoBue","year":"2017","journal-title":"Lancet Infect Dis"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/18\/10\/1669\/66337409\/annalsats_18_10_1669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/18\/10\/1669\/66337409\/annalsats_18_10_1669.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:56:38Z","timestamp":1769072198000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/18\/10\/1669\/8419205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,1]]},"published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202009-1153oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10]]},"published":{"date-parts":[[2021,10,1]]},"assertion":[{"value":"2020-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}